The DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways
Abstract
Several epidemiological studies show an inverse association between cancer and Alzheimer's disease (AD). It is debated whether this association is the consequence of biological mechanisms shared by both these conditions or may be related to the pharmacological treatments carried out on the patients. The latter hypothesis, however, is not sustained by the available evidence. Hence, the focus of this review is to analyze common biological mechanisms for both cancer and AD and to build up a biological theory useful to explain the inverse correlation between AD and cancer. The review proposes a hypothesis, according to which several molecular players, prominently PIN1 and p53, have been investigated and considered involved in complex molecular interactions putatively associated with the inverse correlation. On the other hand, p53 involvement in both diseases seems to be a consequence of the aberrant activation of other proteins. Instead, PIN1 may be identified as a novel key regulator at the crossroad between cancer and AD. PIN1 is a peptidyl-prolyl cis-trans isomerase that catalyzes the cis-trans isomerization, thus regulating the conformation of different protein substrates after phosphorylation and modulating protein function. In particular, trans-conformations of Amyloid Precursor Protein (APP) and tau are functional and "healthy", while cis-conformations, triggered after phosphorylation, are pathogenic. As an example, PIN1 accelerates APP cis-to-trans isomerization thus favo…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alzheimer’s disease (AD) patients have a decreased incidence of cancer.”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [2]
Citations
Cites
2 retracted
Larson, M. E., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., Aguzzi, A., & Lesné, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1858-12.2012 · Cited by 290
RetractedTransactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function
Weisz, L., Zalcenstein, A., Stambolsky, P., Cohen, Y., Goldfinger, N., Oren, M., & Rotter, V. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1145 · Cited by 129
RetractedSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,897
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I. A., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,655
Notch signalling: a simple pathway becomes complex
Bray, S. J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2009 · Cited by 2,620
Research works printed but not linked: 1
- Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 1997;278:1957–60. · DOI
Cited by
Sorted by citations
Items 101–131 of 131
Catalá-López, F., Driver, J. A., Page, M. J., Hutton, B., Ridao-López, M., Berrozpe‐Villabona, C., Alonso‐Arroyo, A., Medín, C. A. F., Bernal‐Delgado, E., Valencia, A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058738 · Cited by 1
Rethinking Alzheimer’s: Novel miRNAs Illuminate a Disease Beyond the Brain
Novotný, J., Čarná, M., Dammer, E., Mao, Z., & Stokin, G. (2025) · doi:10.1101/2025.11.27.690929 · Cited by 1
Multiscale Analysis of the Amyloid Degradation Toxicity Hypothesis of Alzheimer’s DiseasePreprint
Zaretsky, D. V., & Zaretskaia, M. V. (2020) · Preprints.org · doi:10.20944/preprints202012.0813.v1
Mayburd, A. L. (2021) · Research Square · doi:10.21203/rs.3.rs-460229/v1
Saha, S., Soliman, A. T., & Rajasekaran, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.19.465019
Li, M., Cao, X., Yan, H., Wang, M., Tashibolati, A., & Maiwulanjiang, M. (2022) · ChemistrySelect · doi:10.1002/slct.202201364
The Correlation of Cancer and Alzheimer’s through Biochemical Pathways
Kumaran, S. M., & Appavu, R. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i2.2573
Lukic, I. R., Radunović, M., Babić, D., Popović, T., & Popović, N. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-49062-0_6
Gui, Z., Xu, M., Dong, Z., & Wang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3769740/v1
Ha, J., Choi, S., Moon, S., Han, J., Lee, J., Park, S., Wang, S., Han, S., & Min, C. (2024) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2024.08.001
Cancer History and Age-Related Macular Degeneration: Age Appears to be an Influential Factor
Lee, J. H., Hwang, I. C., Lee, Y. J., & Ahn, H. Y. (2024) · 대한임상노인의학회지 · doi:10.15656/kjgg.2024.25.2.99
Pereira, J. D., Tosatti, J. A. G., & Gomes, K. B. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_484
A bird's eye view to the homeostatic, Alzheimer and Glioblastoma attractors
Nieves, J., Gil, G., & Gonzalez, A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42445
Graff, R. E., Chen, D. M., Swinnerton, K. N., Ackley, S. F., Ospina‐Romero, M., Zimmerman, S. C., Wang, J., Buto, P. T., Nierenberg, J. L., Elahi, F. M., et al. (2025) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000696
Liu, W., Xu, B., Ren, X., Chen, Y., Li, G., Zhang, Z., Yang, X., & Liu, J. (2025) · Research Square · doi:10.21203/rs.3.rs-8035932/v1
Xie, H., & Geng, W. (2025) · Medicine · doi:10.1097/md.0000000000046646
Additional file 1 of The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
Jeon, S. G., Lee, H.-J., Park, H., Han, K.-M., & Hoe, H.-S. (2020) · Figshare · doi:10.6084/m9.figshare.13010829
Zhang, D.-D., Ou, Y.-N., Yang, L., Ma, Y.-H., Tan, L., Feng, J.-F., Cheng, W., & Yu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21285752
Morrow, E. H., & Harper, J. A. (2026) · medRxiv · doi:10.64898/2026.02.26.26347171
Neeru, Shukla, A. K., Dhewa, T., & Kumar, A. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00488-w
Ouyang, Z., Liu, F., Lu, Q., Wang, Y., Shao, N., Liu, H. K., & Cai, B. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10734-1
Xiong, X., Li, Y., Zhao, M., Zhao, J., Xiong, S., & Sun, Z. (2026) · Analytical Methods · doi:10.1039/d6ay00468g
Exploring peripheral immune mechanisms and potential therapeutic drugs for Alzheimer’s disease
Zhu, W., Zhou, D., Zhang, G., & Dai, W. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05397-4
Exploring the genetic architecture of multimorbidity and its impact on long COVID riskPreprint
Bauer, S. J. M., Bowyer, R. C. E., Bravo-Merodio, L., GKOUTOS, G., Vetrano, D., Jackson, T., Steves, C. J., & Freidin, M. B. (2026) · medRxiv · doi:10.64898/2026.05.18.26353402
Taha, M. M. E., Abdelwahab, S. I., Alshahrani, S., Jali, A. M., Qadri, M. M., Alarifi, A., & Al-Shamsi, H. O. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05545-w
The cancer Alzheimer’s disease paradox
Feng, L. (2026) · npj Aging · doi:10.1038/s41514-026-00442-1
Ellingson, A., Kalyanasundaram, A., & Orgel, J. P. R. O. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146521 · Cited by 1
Shukla, A. K., Cho, W., Ahn, M., Shukla, S., Upadhyay, A. M., Nagappan, A., Mongre, R. K., & Kim, B. S. (2026) · Bioprinting · doi:10.1016/j.bprint.2026.e00497
Fang, J., & Wang, X. (2026) · Journal of Proteomics · doi:10.1016/j.jprot.2026.105723
Liu, W., Xu, B., 任晓虎, Yang, C., Li, G., Zhang, Z., Yang, X., & Liu, J. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.10.013
Lyu, J. (2026) · Research Square · doi:10.21203/rs.3.rs-11415613/v1
Metadata
- Authors
- Lanni, C., Masi, M., Racchi, M., & Govoni, S.
- Affiliations
- University of Pavia (IT)
- Corresponding author
- Govoni, Stefano
- Venue
- Molecular Psychiatry
- Published
- 2020-05-07
- Volume
- 26
- Issue
- 1
- Pages
- 280-295
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W3022858905
- Cited by
- 130
- References
- 212
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 26 · 2023: 17 · 2022: 27 · 2021: 15 · 2020: 5
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cancer, inverse association, Pin1, peptidyl-prolyl isomerase, p53, amyloid precursor protein, tau hyperphosphorylation, non-amyloidogenic pathway, amyloidogenic pathway, mild cognitive impairment, age of onset, cancer risk, neurodegenerative dementia
- MeSH terms
- NIMA-Interacting Peptidylprolyl Isomerase, Aging, Alzheimer Disease, Humans, Neoplasms, Phosphorylation, Tumor Suppressor Protein p53, Amyloid beta-Protein Precursor, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
